| Product Code: ETC8861488 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Poland drug-device combination products market, the import trend showed a notable growth rate of 14.4% from 2023 to 2024, with a compound annual growth rate (CAGR) of 10.44% for the period 2020-2024. This upward momentum in imports can be attributed to increased demand for innovative medical technologies and favorable trade policies that supported market stability during this period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Drug-Device Combination Products Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Drug-Device Combination Products Market Revenues & Volume, 2022 & 2032F |
3.3 Poland Drug-Device Combination Products Market - Industry Life Cycle |
3.4 Poland Drug-Device Combination Products Market - Porter's Five Forces |
3.5 Poland Drug-Device Combination Products Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Poland Drug-Device Combination Products Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Poland Drug-Device Combination Products Market Revenues & Volume Share, By End user, 2022 & 2032F |
4 Poland Drug-Device Combination Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Poland leading to the need for efficient treatment options. |
4.2.2 Growing demand for personalized medicine and targeted therapies. |
4.2.3 Technological advancements in drug-device combination products improving treatment outcomes. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for drug-device combination products. |
4.3.2 Limited awareness and understanding among healthcare professionals and patients. |
4.3.3 High development costs and pricing pressures in the market. |
5 Poland Drug-Device Combination Products Market Trends |
6 Poland Drug-Device Combination Products Market, By Types |
6.1 Poland Drug-Device Combination Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Poland Drug-Device Combination Products Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 Poland Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting stents, 2022-2032F |
6.1.4 Poland Drug-Device Combination Products Market Revenues & Volume, By Infusion pumps, 2022-2032F |
6.1.5 Poland Drug-Device Combination Products Market Revenues & Volume, By Photodynamic therapy, 2022-2032F |
6.1.6 Poland Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial wound dressings, 2022-2032F |
6.1.7 Poland Drug-Device Combination Products Market Revenues & Volume, By Prefilled syringes, 2022-2032F |
6.1.8 Poland Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting balloons, 2022-2032F |
6.1.9 Poland Drug-Device Combination Products Market Revenues & Volume, By Other, 2022-2032F |
6.1.10 Poland Drug-Device Combination Products Market Revenues & Volume, By Other, 2022-2032F |
6.2 Poland Drug-Device Combination Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Poland Drug-Device Combination Products Market Revenues & Volume, By Cardiovascular Disorders, 2022-2032F |
6.2.3 Poland Drug-Device Combination Products Market Revenues & Volume, By Diabetes, 2022-2032F |
6.2.4 Poland Drug-Device Combination Products Market Revenues & Volume, By Respiratory Problems, 2022-2032F |
6.2.5 Poland Drug-Device Combination Products Market Revenues & Volume, By Cancer Treatment, 2022-2032F |
6.2.6 Poland Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial Application, 2022-2032F |
6.2.7 Poland Drug-Device Combination Products Market Revenues & Volume, By Other, 2022-2032F |
6.3 Poland Drug-Device Combination Products Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Poland Drug-Device Combination Products Market Revenues & Volume, By Hospital & clinic, 2022-2032F |
6.3.3 Poland Drug-Device Combination Products Market Revenues & Volume, By Ambulatory surgery center (asc), 2022-2032F |
6.3.4 Poland Drug-Device Combination Products Market Revenues & Volume, By Home care setting, 2022-2032F |
6.3.5 Poland Drug-Device Combination Products Market Revenues & Volume, By Other, 2022-2032F |
7 Poland Drug-Device Combination Products Market Import-Export Trade Statistics |
7.1 Poland Drug-Device Combination Products Market Export to Major Countries |
7.2 Poland Drug-Device Combination Products Market Imports from Major Countries |
8 Poland Drug-Device Combination Products Market Key Performance Indicators |
8.1 Adoption rate of drug-device combination products by healthcare facilities in Poland. |
8.2 Number of clinical trials and research studies conducted on drug-device combination products. |
8.3 Rate of reimbursement approvals for drug-device combination products by healthcare payers in Poland. |
9 Poland Drug-Device Combination Products Market - Opportunity Assessment |
9.1 Poland Drug-Device Combination Products Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Poland Drug-Device Combination Products Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Poland Drug-Device Combination Products Market Opportunity Assessment, By End user, 2022 & 2032F |
10 Poland Drug-Device Combination Products Market - Competitive Landscape |
10.1 Poland Drug-Device Combination Products Market Revenue Share, By Companies, 2025 |
10.2 Poland Drug-Device Combination Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here